**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de cyclosporose aux États-Unis d'ici le 31 août ?
Cas de cyclosporose aux États-Unis d'ici le 31 août ?
$13,103 Vol.
31 août 2026
10 000+
Oui
15 000+
Oui
20 000+
Non
$13,103 Vol.
10 000+
$2,454 Vol.
Oui
15 000+
$4,592 Vol.
Oui
20 000+
$6,057 Vol.
Non
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Marché ouvert : Jul 27, 2026, 11:16 PM ET
Volume
$13,103Date de fin
1 sept. 2026Marché ouvert
Jul 27, 2026, 11:16 PM ETRésolveur
0x65070BE91...Résultat proposé: Oui
Aucune contestation
Résultat final: Oui
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$13,103Date de fin
1 sept. 2026Marché ouvert
Jul 27, 2026, 11:16 PM ETRésolveur
0x65070BE91...Résultat proposé: Oui
Aucune contestation
Résultat final: Oui
**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes